Oncomfort, a Wavre near Brussels, Belgium-based Digital SedationTM company, completed a €10m Series A funding.
Miracor Medical SA, an Awans, Belgium-based provider of innovative solutions for the treatment of severe cardiac diseases, closed a €24M Series E round of financing.
Indigo Diabetes, a Ghent, Belgium-based medical device company developing a novel invisible sensor for diabetes, raised €38M in Series B financing.
Boehringer Ingelheim, an Ingelheim, Germany-based market leader in animal health, acquired Global Stem cell Technology (GST), a Belgian veterinary biotech company.
Skipr, a Brussels, Belgium-based B2B Mobility as a Service startup, raised €7m in funding.
eTheRNA immunotherapies, a Niel, Belgium-based clinical-stage company developing immunotherapies from its proprietary mRNA TriMix platform for the treatment of cancer and infectious diseases, raised Euro €34m in a Series B equity financing round.
BioStrand, a Belgian startup that is advancing technology for analyzing genetic data, raised €2m in funding.
Mastercard (NYSE: MA) appointed Mark Barnett as President of its European business, based in Brussels.
Hyloris Pharmaceuticals, a Liège, Belgium–based innovative specialty pharmaceutical company, raised €15m in funding.
Deliverect, a Ghent, Belgium-based startup streamlining the restaurant industry with its online food delivery management software, raised €16.25m in Series B funding.
InvestSuite, a Leuven, Belgium-based B2B WealthTech startup, raised €2m in funding.
Collibra, a Brussels, Belgium-based data intelligence company, raised $112.5m in funding at a post-money valuation of $2.3 billion.
The European Commission is calling for startups and SMEs with technologies and innovations that could help in treating, testing, monitoring or other aspects of the Coronavirus outbreak to apply urgently to the next round of funding from the European Innovation Council.
Based in Mechelen, Belgium, Customs4trade has created a comprehensive customs and trade compliance platform. The company has just raised an additional €3m in equity funding in a round which brought total funding raised to date to over €5.1m.
OncoDNA, a Gosselies, Belgium-based healthcare technology company focusedd on precision medicine, raised €19m ($20m) in Series B equity financing.